Ensysce Biosciences (ENSC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.52, -13.33% vs the prior close of $0.60.
- Volume 490.29K shares, 0.0x its 50-day average (light).
- New SEC filings: 8-K/A (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
ENSC slides 13.3% to $0.52. Closed at $0.52, -13.33% vs the prior close of $0.60. Day range $0.50–$0.59, opened at $0.59.
ENSC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ENSC slides 13.3% to $0.52
- Closed at $0.52, -13.33% vs the prior close of $0.60. Day range $0.50–$0.59, opened at $0.59.
- Volume was 490.29K shares, 0.0x its 50-day average of 11.58M — lighter than usual.
- Price is +18.2% vs its 50-day average ($0.44) and +13.3% vs its 200-day average ($0.46).
- 52-week range $0.23–$2.75; today's close sits at 11% of that range, 81.2% below the 52-week high.
Oct 15, 2026 — ENSC jumps 6.6% to $0.60, a 6-month high
- Closed at $0.60, +6.60% vs the prior close of $0.56. Day range $0.55–$0.60, opened at $0.56.
- Volume was 323.20K shares, 0.0x its 50-day average of 11.73M — lighter than usual.
- Price is +36.3% vs its 50-day average ($0.44) and +30.1% vs its 200-day average ($0.46).
- 52-week range $0.23–$2.75; today's close sits at 15% of that range, 78.3% below the 52-week high.
Oct 14, 2026 — ENSC dips 2.1% to $0.56
- Closed at $0.56, -2.09% vs the prior close of $0.57. Day range $0.53–$0.57, opened at $0.56.
- Volume was 415.00K shares, 0.0x its 50-day average of 15.36M — lighter than usual.
- Price is +29.2% vs its 50-day average ($0.43) and +21.5% vs its 200-day average ($0.46).
- 52-week range $0.23–$2.75; today's close sits at 13% of that range, 79.6% below the 52-week high.
Oct 13, 2026 — ENSC jumps 3.1% to $0.57, a 6-month high, 4 up days in a row
- Closed at $0.57, +3.06% vs the prior close of $0.56. Day range $0.53–$0.62, opened at $0.54.
- Volume was 1.22M shares, 0.1x its 50-day average of 17.79M — lighter than usual.
- Price is +33.1% vs its 50-day average ($0.43) and +23.4% vs its 200-day average ($0.46).
- 52-week range $0.23–$2.75; today's close sits at 14% of that range, 79.2% below the 52-week high.
- That makes 4 straight gains.
Oct 12, 2026 — ENSC jumps 5.5% to $0.56, a 6-month high, 3 up days in a row
- Closed at $0.56, +5.50% vs the prior close of $0.53. Day range $0.49–$0.56, opened at $0.51.
- Volume was 1.32M shares, 0.1x its 50-day average of 17.76M — lighter than usual.
- Price is +30.9% vs its 50-day average ($0.42) and +19.0% vs its 200-day average ($0.47).
- 52-week range $0.23–$2.75; today's close sits at 13% of that range, 79.8% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — ENSC jumps 15.1% to $0.53, a 3-month high
- Closed at $0.53, +15.07% vs the prior close of $0.46. Day range $0.48–$0.55, opened at $0.48.
- Volume was 2.68M shares, 0.2x its 50-day average of 17.71M — lighter than usual.
- Price is +25.9% vs its 50-day average ($0.42) and +12.1% vs its 200-day average ($0.47).
- 52-week range $0.23–$2.75; today's close sits at 12% of that range, 80.8% below the 52-week high.
Oct 8, 2026 — ENSC jumps 6.8% to $0.46
- Closed at $0.46, +6.76% vs the prior close of $0.43. Day range $0.40–$0.47, opened at $0.44.
- Volume was 1.26M shares, 0.1x its 50-day average of 17.69M — lighter than usual.
- Price is +10.8% vs its 50-day average ($0.41) and -3.2% vs its 200-day average ($0.47).
- 52-week range $0.23–$2.75; today's close sits at 9% of that range, 83.3% below the 52-week high.
Oct 7, 2026 — ENSC ends flat (-0.2%) to $0.43
- Closed at $0.43, -0.23% vs the prior close of $0.43. Day range $0.42–$0.44, opened at $0.44.
- Volume was 195.10K shares, 0.0x its 50-day average of 17.69M — lighter than usual.
- Price is +4.9% vs its 50-day average ($0.41) and -10.0% vs its 200-day average ($0.48).
- 52-week range $0.23–$2.75; today's close sits at 8% of that range, 84.4% below the 52-week high.
Oct 6, 2026 — ENSC rises 2.6% to $0.43
- Closed at $0.43, +2.63% vs the prior close of $0.42. Day range $0.41–$0.44, opened at $0.42.
- Volume was 540.30K shares, 0.0x its 50-day average of 17.69M — lighter than usual.
- Price is +6.0% vs its 50-day average ($0.41) and -10.5% vs its 200-day average ($0.48).
- 52-week range $0.23–$2.75; today's close sits at 8% of that range, 84.4% below the 52-week high.
Oct 5, 2026 — ENSC jumps 6.1% to $0.42
- Closed at $0.42, +6.08% vs the prior close of $0.40. Day range $0.39–$0.44, opened at $0.39.
- Volume was 601.30K shares, 0.0x its 50-day average of 17.68M — lighter than usual.
- Price is +4.2% vs its 50-day average ($0.40) and -13.4% vs its 200-day average ($0.48).
- 52-week range $0.23–$2.75; today's close sits at 7% of that range, 84.8% below the 52-week high.
Oct 2, 2026 — ENSC dips 1.2% to $0.40, a 1-month low, 3 down days in a row
- Closed at $0.40, -1.25% vs the prior close of $0.40. Day range $0.39–$0.43, opened at $0.41.
- Volume was 173.20K shares, 0.0x its 50-day average of 17.68M — lighter than usual.
- Price is -1.0% vs its 50-day average ($0.40) and -19.0% vs its 200-day average ($0.49).
- 52-week range $0.23–$2.75; today's close sits at 7% of that range, 85.6% below the 52-week high.
- That makes 3 straight losses.
ENSC latest news & SEC filings
Every SEC filing by or about ENSC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 18, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gower Bob G bought 400,000 shares at $0.50 (≈$200.00K) on Aug 7, 2026
- Gower Bob G bought 400,000 shares at $0.50 (≈$200.00K) on Aug 7, 2026
- Gower Bob G bought 400,000 shares at $0.50 (≈$200.00K) on Aug 7, 2026
- Gower Bob G bought 400,000 shares at $0.50 (≈$200.00K) on Aug 7, 2026
- Gower Bob G bought 508,614 shares at $0.48 (≈$244.13K) on Apr 23, 2026
- Gower Bob G bought 508,614 shares at $0.48 (≈$244.13K) on Apr 23, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.16M (prior year $1.37M) (-15.1% vs Jun 30, 2025)
- Diluted EPS: -$0.20 (prior year -$0.79) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 10, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 6, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Exhibits / financial statements only (Item 9.01).
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 3.02 — Sold unregistered shares.
- Item 3.03 — Change to shareholder rights.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jul 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jun 26, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Things to know before you trade ENSC
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Mar 30, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.66% (largest 15.1%). That is a volatile stock.
- Liquidity: about 584.78K shares (≈$303.09K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.52 vs a range of $0.23–$2.75 (11% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Dec 6, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Bob G Gower bought 400,000 shares on Aug 7, 2026.
- Latest filings: 8-K Sep 29, 2026; 8-K Aug 25, 2026; 8-K Aug 24, 2026.
- Share count: 19.46M shares outstanding (Aug 12, 2026), +555.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ENSC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.59 | 0.59 | 0.50 | 0.52 | 490.29K |
| Oct 15, 2026 | 0.56 | 0.60 | 0.55 | 0.60 | 323.20K |
| Oct 14, 2026 | 0.56 | 0.57 | 0.53 | 0.56 | 415.00K |
| Oct 13, 2026 | 0.54 | 0.62 | 0.53 | 0.57 | 1.22M |
| Oct 12, 2026 | 0.51 | 0.56 | 0.49 | 0.56 | 1.32M |
| Oct 9, 2026 | 0.48 | 0.55 | 0.48 | 0.53 | 2.68M |
| Oct 8, 2026 | 0.44 | 0.47 | 0.40 | 0.46 | 1.26M |
| Oct 7, 2026 | 0.44 | 0.44 | 0.42 | 0.43 | 195.10K |
| Oct 6, 2026 | 0.42 | 0.44 | 0.41 | 0.43 | 540.30K |
| Oct 5, 2026 | 0.39 | 0.44 | 0.39 | 0.42 | 601.30K |
| Oct 2, 2026 | 0.41 | 0.43 | 0.39 | 0.40 | 173.20K |
| Oct 1, 2026 | 0.42 | 0.42 | 0.40 | 0.40 | 198.90K |
| Sep 30, 2026 | 0.41 | 0.43 | 0.41 | 0.42 | 349.20K |
| Sep 29, 2026 | 0.40 | 0.43 | 0.40 | 0.42 | 167.70K |
| Sep 28, 2026 | 0.41 | 0.42 | 0.40 | 0.40 | 210.30K |
| Sep 25, 2026 | 0.41 | 0.42 | 0.40 | 0.41 | 141.80K |
| Sep 24, 2026 | 0.43 | 0.43 | 0.40 | 0.40 | 319.60K |
| Sep 23, 2026 | 0.43 | 0.44 | 0.41 | 0.41 | 363.00K |
| Sep 22, 2026 | 0.43 | 0.44 | 0.42 | 0.43 | 200.90K |
| Sep 21, 2026 | 0.45 | 0.46 | 0.42 | 0.42 | 537.70K |
About Ensysce Biosciences
Ensysce Biosciences (ENSC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LA JOLLA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1716947.
ENSC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Bob G Gower | Director | Aug 18, 2026 |
| James William Morrison | President | Aug 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James William Morrison | President | Aug 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Bob G Gower | Buy | 400,000 | $0.50 |
| Aug 7, 2026 | Bob G Gower | Buy | 400,000 | $0.50 |
| Aug 7, 2026 | Bob G Gower | Buy | 400,000 | $0.50 |
| Aug 7, 2026 | Bob G Gower | Buy | 400,000 | $0.50 |
| Apr 23, 2026 | Bob G Gower | Buy | 508,614 | $0.48 |
| Apr 23, 2026 | Bob G Gower | Buy | 508,614 | $0.48 |
| Apr 23, 2026 | Bob G Gower | Buy | 508,614 | $0.48 |
| Apr 23, 2026 | Bob G Gower | Buy | 508,614 | $0.48 |
ENSC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.07M | — | -3.98 | $-7.81M |
| Dec 31, 2024 | $5.21M | — | -11.45 | $-7.50M |
| Dec 31, 2023 | $2.23M | — | -70.40 | $-10.78M |
| Dec 31, 2022 | $2.52M | — | -139.42 | $-17.89M |
| Dec 31, 2021 | $3.53M | — | -1.48 | $-8.24M |
Latest balance sheet: total assets $2.96M, total liabilities $4.07M, cash $676.70K (as of Jun 30, 2026).
ENSC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $0.35 |
| May 15, 2026 | 8-K Item 2.02 (results) | $0.28 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $0.51 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $2.06 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $2.15 |
| May 13, 2025 | 8-K Item 2.02 (results) | $2.07 |
| Mar 10, 2025 | 8-K Item 2.02 (results) | $4.83 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $10.12 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 13, 2024 | 8-K Item 2.02 (results) | — |
| Mar 15, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ENSC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.